Viewing nowRotain Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Huons Life Science Co., Ltd.

MFDS item code 200503652 · Notified 2005.03.28
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
This medication is used to treat hypertension. It is particularly effective in preventing and treating kidney disease in patients with type 2 diabetes who have hypertension. By controlling blood pressure, it helps prevent deterioration of kidney function and maintain health. Therefore, it plays an important role in managing hypertension and kidney disease related to diabetes.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to up to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when used in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this drug is 50 mg once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is necessary for elderly patients 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years and older weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus; it must be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication, severe liver dysfunction, certain genetic disorders, and women who are pregnant or may become pregnant should not take it. Elderly patients or those with impaired kidney function and patients at risk of excessively low blood pressure should use this medication cautiously, requiring regular monitoring. This medication is primarily used for the treatment of hypertension and typically has few side effects; however, symptoms such as dizziness, muscle cramps, back pain, cough, and dyspepsia may occur. Blood pressure may drop too low or kidney function may worsen, so any symptoms should prompt immediate consultation with a healthcare professional. Due to the risk of increased potassium levels, patients should avoid taking potassium supplements or medications containing potassium. This medication may interact with other antihypertensives, certain diuretics, NSAIDs, etc.; therefore, if taking other medications, it is crucial to inform a doctor or pharmacist. Pregnant or breastfeeding women are advised to avoid taking this medication, and breastfeeding should be discontinued if already taking it. It is advisable not to use this medication in children or patients with severely impaired kidney function, as safety has not been established. Regular checks of blood pressure, kidney function, and electrolyte levels should be conducted to ensure no abnormalities occur during use. Dizziness or drowsiness may occur while taking this medication, so caution is required when driving or operating machinery.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Huons Life Science Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.